title: Glial expression of interleukin-18 and its receptor after excitotoxic damage in the mouse hippocampus.
abstract: Interleukin (IL)-18, a member of the IL-1 cytokine family, is an important mediator of peripheral inflammation and host defence responses. However, although IL-1 is a key proinflammatory cytokine in the brain, little is known about IL-18 changes in glial cells under excitotoxic neurodegeneration. In this study, we characterized the expressions of IL-18 and IL-18 receptor (IL-18R) in kainic acid (KA)-induced excitotoxicity in mouse hippocampus by immunohistochemistry and Western blotting. IL-18 immunoreactivity was found in microglia whereas IL-18R immunoreactivity was observed in astrocytes. Levels of IL-18 and IL-18R in hippocampus homogenates increased progressively from day 1 post-KA and peaked at 3 days. This study demonstrates the cellular sources of IL-18 and IL-18R, and their temporal correlations after KA-insult, and suggests roles for IL-18 and IL-18R in glial cells in response to excitotoxic damage in the hippocampus.
authors: Department of Anatomy, Seoul National University College of Medicine, 28 Yongon-Dong, Chongno-Gu, Seoul, 110-799, South Korea.
authors: Gye Sun
authors: GS
authors: Jeon
authors: Sung Kyung
authors: SK
authors: Park
authors: Sang Wook
authors: SW
authors: Park
authors: Dong Woon
authors: DW
authors: Kim
authors: Chun Kee
authors: CK
authors: Chung
authors: Sa Sun
authors: SS
authors: Cho
mesh_terms: D000818:Animals; D015153:Blotting, Western; D006624:Hippocampus / Q000187:drug effects* / Q000378:metabolism; D007150:Immunohistochemistry; D020382:Interleukin-18 / Q000378:metabolism*; D007608:Kainic Acid / Q000633:toxicity*; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009457:Neuroglia / Q000378:metabolism*; D053724:Receptors, Interleukin-18 / Q000378:metabolism*
chemical_list: D020382:Interleukin-18; D053724:Receptors, Interleukin-18; D007608:Kainic Acid
references: J Comp Neurol. 1980 Jul 15;192(2):333-59
references: 7400401
references: Exp Neurol. 2007 May;205(1):64-73
references: 17316614
references: J Neurosci. 2002 Jul 15;22(14):5910-9
references: 12122053
references: Brain Res Mol Brain Res. 1998 Jun 1;57(1):1-9
references: 9630473
references: J Neuroimmunol. 2001 Mar 1;114(1-2):253-8
references: 11240039
references: Brain Res Mol Brain Res. 2000 May 5;77(2):290-3
references: 10837926
references: Neurosci Lett. 2005 Jan 3;373(1):16-20
references: 15555769
references: J Neurosci Res. 2001 Aug 15;65(4):332-9
references: 11494369
references: Ann Neurol. 2004 Jan;55(1):46-57
references: 14705111
references: Eur J Neurosci. 2000 Jul;12(7):2623-33
references: 10947836
references: J Leukoc Biol. 2003 Feb;73(2):213-24
references: 12554798
references: Glia. 2004 Nov 15;48(3):250-8
references: 15390117
references: Annu Rev Immunol. 2001;19:423-74
references: 11244043
references: Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11534-9
references: 11016948
references: J Neuroimmunol. 2003 Dec;145(1-2):40-5
references: 14644029
references: J Neurochem. 1999 May;72(5):2215-8
references: 10217305
references: Cytokine. 2006 Sep;35(5-6):229-34
references: 17052916
references: Neurobiol Dis. 2006 Mar;21(3):457-67
references: 16202616
references: Virology. 2001 Aug 15;287(1):163-70
references: 11504551
references: Brain Res. 2006 Nov 22;1121(1):35-45
references: 17010950
references: J Pharmacol Methods. 1986 Dec;16(4):355-7
references: 3784576
references: Immunol Lett. 2006 Nov 15;107(2):125-30
references: 17014914
references: Mol Psychiatry. 1998 Jul;3(4):362-6
references: 9702748
references: J Interferon Cytokine Res. 2006 Oct;26(10):706-18
references: 17032165
references: J Cereb Blood Flow Metab. 2002 Jan;22(1):62-70
references: 11807395